Overall, CD36 expression in the liver increased significantly in both patients with NAFLD and mouse models; in parallel with CD36 expression, fatty acid uptake increased significantly, indicating that CD36 is closely related to the development of fatty liver. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.